Amino acids and Derivatives

Custom Peptide Synthesis

Amino acids and Derivatives (1367):

Cat. No.	Product Name	CAS No.	Purity	Chemical Structure

PAβN dihydrochloride	100929-99-5	99.89%
PAβN dihydrochloride (MC-207110 dihydrochloride) is an efflux pump inhibitor.

α-Methyl-DL-aspartic acid	2792-66-7	99.92%
α-Methyl-DL-aspartic acid is a specific inhibitor of argininosuccinate synthase (ASS), and also is the rate-limiting enzyme for the recycling of 1-citrulline to 1-arginine.

Fmoc-Arg(Pbf)-OH	154445-77-9	99.97%
Fmoc-Arg(Pbf)-OH is an arginine derivative containing amine protecting group Fmoc. Fmoc-Arg(Pbf)-OH is a building block for the introduction of Arg into SPPS (Solid-Phase Peptide Synthesis).

L-Tyrosine disodium salt	69847-45-6	99.79%
L-Tyrosine (disodium) is a tyrosine derivative.

tert-Butyl 2-aminoacetate	6456-74-2	99.64%
tert-Butyl 2-aminoacetate is a Glycine (HY-Y0966) derivative.

tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu	1118767-16-0
tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu is an intermediate in the synthesis of the glucagon-like peptide 1 receptor (GLP-1R) agonist Semaglutide (HY-114118).

Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH	2460751-66-8
Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH is a side chain of tirzepatide.

Fmoc-Glu(biotinyl-PEG)-OH	817169-73-6
Fmoc-Glu(biotinyl-PEG)-OH is a glutamic acid derivative.

N6-Diazo-L-Fmoc-lysine	159610-89-6	99.84%
N6-Diazo-L-Fmoc-lysine is an active compand and can be used in a variety of chemical studies. N6-Diazo-L-Fmoc-lysine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.

Fmoc-Gly-OH	29022-11-5	99.98%
Fmoc-Gly-OH (Fmoc glycine) is a Fmoc-protected glycine derivative, can be used for the synthesis of compounds.

DL-Propargylglycine	50428-03-0	≥98.0%
DL-Propargylglycine is a Glycine (HY-Y0966) derivative. DL-Propargylglycine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

Nα,Nα-Bis(carboxymethyl)-L-lysine	113231-05-3	98.80%
Nα,Nα-Bis(carboxymethyl)-L-lysine is a competitive inhibitor of bitter taste receptor 4, with an IC₅₀ of 59 nM. Nα,Nα-Bis(carboxymethyl)-L-lysine can be used in bitter receptors related study.

Fmoc-Asp(OtBu)-OH	71989-14-5	99.85%
Fmoc-Asp(OtBu)-OH (4-tert-Butyl N-(fluoren-9-ylmethoxycarbonyl)-L-aspartate) is an aspartate derivative containing amine protecting group Fmoc. Fmoc-Asp(OtBu)-OH can be used for peptide synthesis.

Fmoc-Ala-OH	35661-39-3	99.92%
Fmoc-Ala-OH is an alanine derivative.

L-tert-Leucine Methyl Ester Hydrochloride	63038-27-7	≥98.0%
L-tert-Leucine Methyl Ester Hydrochloride is a leucine derivative.

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid	71989-18-9	99.93%
(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid is a glutamic acid derivative.

Fmoc-L-Lys (Boc)-OH	71989-26-9	99.98%
Fmoc-L-Lys (Boc)-OH is a lysine derivative.

Fmoc-Glu(OAll)-OH	133464-46-7	99.45%
Fmoc-Glu(OAll)-OH is a glutamic acid derivative.

Fmoc-Lys-OH	105047-45-8	99.93%
Fmoc-Lys-OH is a lysine derivative.

Fmoc-Hyp(tBu)-OH	122996-47-8	99.28%
Fmoc-Hyp(tBu)-OH is a proline derivative.

MedChemExpress Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator; DNA/RNA sequence conversion tools

Subscribe to our E-newsletter

Name
Email *

	Sorry, but the email address you supplied was invalid.

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2025 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us